818968008: Trifarotene (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Retinoid (substance)\Trifarotene (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic cyclic compound\Substance with phenol structure\Terphenyl\Trifarotene (substance)

\Hydrocarbon\Terpene (substance)\Carotinoid (substance)\Retinoid (substance)\Trifarotene (substance)
\Hydrocarbon\Aromatic hydrocarbon\Substance with benzene structure\Benzene derivative hydrocarbon\Terphenyl\Trifarotene (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3856376018 Trifarotene (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3856377010 Trifarotene en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Trifarotene (substance)	Is a	Terphenyl	true	Inferred relationship	Some
Trifarotene (substance)	Is a	Retinoid (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing trifarotene in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Trifarotene (substance)	Inferred relationship	Some	1
Trifarotene only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Trifarotene (substance)	Inferred relationship	Some	1
Product containing only trifarotene (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Trifarotene (substance)	Inferred relationship	Some	1
Product containing trifarotene (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Trifarotene (substance)	Inferred relationship	Some	1
Product containing precisely trifarotene 50 microgram/1 gram conventional release cutaneous cream (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Trifarotene (substance)	Inferred relationship	Some	1
Product containing precisely trifarotene 50 microgram/1 gram conventional release cutaneous cream (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Trifarotene (substance)	Inferred relationship	Some	1

This concept is not in any reference sets